Noxsano
Noxsano is a wound care company dedicated to developing medical treatments for both human and veterinary applications. Their innovative technology delivers nitric oxide to enhance wound healing, making it effective for treating acute and chronic wounds. Noxsano's products are designed to be convenient, affordable, and clinically proven to accelerate healing times while reducing costs.
Industries
Nr. of Employees
small (1-50)
Patents
Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
2019-07-09 • US-10342706-B2
View Details
Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
2019-07-09 • US-10342706-B2
View DetailsProducts
Water-activated nitric-oxide generating wound pad (single-use pouch)
Individually pouch-packaged wound pads constructed from non-woven layers with embedded absorbent gelling material and reactants; hydrated in-pouch and applied directly to wounds to deliver nitric oxide locally.
Water-activated nitric-oxide hydrogel (syringe)
Hydrogel precursor supplied in syringes; user fills syringe with water or saline, mixes to set gel, and applies directly to wound beds for irregular or deep wounds.
Clinical and educational literature downloads
Downloadable brochures, product overviews, instruction sheets, MSDS documents, and links to peer-reviewed literature on nitric oxide and wound healing.
Water-activated nitric-oxide generating wound pad (single-use pouch)
Individually pouch-packaged wound pads constructed from non-woven layers with embedded absorbent gelling material and reactants; hydrated in-pouch and applied directly to wounds to deliver nitric oxide locally.
Water-activated nitric-oxide hydrogel (syringe)
Hydrogel precursor supplied in syringes; user fills syringe with water or saline, mixes to set gel, and applies directly to wound beds for irregular or deep wounds.
Clinical and educational literature downloads
Downloadable brochures, product overviews, instruction sheets, MSDS documents, and links to peer-reviewed literature on nitric oxide and wound healing.
Expertise Areas
- Topical wound care
- Point-of-use nitric oxide delivery systems
- Hydrogel formulation for wound treatment
- Absorbent gelling material dressings
Key Technologies
- Topical nitric oxide generation (water-activated chemical delivery)
- Hydrogel wound dressings
- Absorbent gelling materials (AGM) in dressings
- Single-use pouch packaging for point-of-use activation
Key People
Alan Willey
CEO
Jacob Adams
CSO
Stevan Samuel
COO
Ray Shealy
Cofounder
Randy Watson
Marketing Director
Alan Willey
CEO
Jacob Adams
CSO
Stevan Samuel
COO
Ray Shealy
Cofounder
Randy Watson
Marketing Director
Investors
Series A - Noxsano
$800,000 funded.
Announced on 2022-07-01.
Nashville Entrepreneur Center
Announced on 2020-08-06.
Series A - Noxsano
$2,000,000 funded.
Announced on 2019-07-01.
Rev1 Ventures
$175,000 funded.
Announced on 2017-08-17.
Series A - Noxsano
$800,000 funded.
Announced on 2022-07-01.
Nashville Entrepreneur Center
Announced on 2020-08-06.
Series A - Noxsano
$2,000,000 funded.
Announced on 2019-07-01.
Rev1 Ventures
$175,000 funded.
Announced on 2017-08-17.